MedTrace Logo

Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers

NCT00347815 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2006-07-04

No results posted yet for this study

Summary

The purpose of this study is to determine the amount of buprenorphine and its metabolites in blood and urine after administration of 0.6 mg buprenorphine in healthy volunteers. Furthermore the purpose is to correlate the amount of buprenorphine in the blood with the effect on the ability to concentrate and coordinate.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Buprenorphine

Sponsors & Collaborators

  • Danish University of Pharmaceutical Sciences

    lead OTHER

Principal Investigators

  • Niels-Henrik Jensen, MD · Multidisciplinary Pain Centre, Herlev Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-30
Completion
2006-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00347815 on ClinicalTrials.gov